南新制药
(688189)
| 流通市值：22.23亿 | | | 总市值：22.23亿 |
| 流通股本：2.74亿 | | | 总股本：2.74亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 550,365,903.94 | 490,270,275.37 | 389,076,108.51 | 529,023,183.42 |
| 应收票据及应收账款 | 112,999,233.88 | 196,319,324.59 | 428,454,171.37 | 504,056,510.08 |
| 其中：应收票据 | 376,650 | 721,754.4 | 532,310.5 | 305,513 |
| 应收账款 | 112,622,583.88 | 195,597,570.19 | 427,921,860.87 | 503,750,997.08 |
| 应收款项融资 | 7,291,255.42 | 3,581,332 | 928,842.83 | 5,011,488.22 |
| 预付款项 | 15,638,474.98 | 9,690,467.49 | 16,775,635.27 | 9,690,928.94 |
| 其他应收款合计 | 2,024,999.34 | 1,088,388.01 | 1,885,861.81 | 1,879,951.24 |
| 存货 | 54,225,122.03 | 61,166,785.39 | 67,051,501.23 | 41,384,600.6 |
| 其他流动资产 | 16,345,732.3 | 16,233,089.43 | 6,978,763.08 | 3,382,843.67 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 758,890,721.89 | 778,349,662.28 | 911,150,884.1 | 1,094,429,506.17 |
| 非流动资产: | | | | |
| 固定资产 | 160,055,330.82 | 163,557,095.29 | 171,700,405.14 | 176,584,110.91 |
| 在建工程 | 372,188.67 | 353,320.75 | 592,943.39 | 592,943.39 |
| 使用权资产 | 187,867.46 | 387,350.15 | 479,304.2 | 678,786.89 |
| 无形资产 | 139,053,372.84 | 143,134,999.08 | 133,116,642.82 | 136,839,086.84 |
| 开发支出 | 91,830,077.28 | 77,368,756.53 | 74,405,714.68 | 60,512,530.71 |
| 商誉 | - | - | 10,845,017.78 | 10,845,017.78 |
| 长期待摊费用 | 464,526.86 | 130,459.9 | 480,909.76 | 558,092.82 |
| 递延所得税资产 | 51,078,733.18 | 51,165,836.25 | 60,233,757.53 | 58,672,392.71 |
| 其他非流动资产 | 10,205,506.93 | 7,991,010 | 5,555,385.31 | 3,242,720 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 453,247,604.04 | 444,088,827.95 | 457,410,080.61 | 448,525,682.05 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,212,138,325.93 | 1,222,438,490.23 | 1,368,560,964.71 | 1,542,955,188.22 |
| 流动负债: | | | | |
| 短期借款 | 219,044,141.67 | 218,186,641.67 | 65,050,555.56 | 155,120,555.55 |
| 应付票据及应付账款 | 28,705,587.55 | 39,590,610.58 | 44,016,762.43 | 33,192,748.17 |
| 应付账款 | 28,705,587.55 | 39,590,610.58 | 44,016,762.43 | 33,192,748.17 |
| 合同负债 | 7,617,760.94 | 1,717,411.28 | 11,691,693.17 | 21,693,440.24 |
| 应付职工薪酬 | 10,141,365.4 | 10,699,517.23 | 5,135,221.93 | 8,010,059.71 |
| 应交税费 | 1,845,091.51 | 1,262,383.41 | 2,094,711.17 | 6,535,428.54 |
| 其他应付款合计 | 59,079,155.73 | 57,393,552.17 | 24,920,386.99 | 21,380,443.12 |
| 一年内到期的非流动负债 | - | 708,264.95 | 372,034.34 | 536,115.46 |
| 其他流动负债 | 10,833,369.72 | 10,294,252.69 | 478,875.2 | 2,490,687.41 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 337,266,472.52 | 339,852,633.98 | 153,760,240.79 | 248,959,478.2 |
| 非流动负债: | | | | |
| 租赁负债 | 743,173.65 | 228,071.82 | 695,500.53 | 724,582.53 |
| 递延收益 | 2,925,000 | 3,000,000 | 3,075,000 | 3,150,000 |
| 递延所得税负债 | 999,313.31 | 1,051,908.75 | 1,373,942.26 | 1,426,537.69 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 4,667,486.96 | 4,279,980.57 | 5,144,442.79 | 5,301,120.22 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 341,933,959.48 | 344,132,614.55 | 158,904,683.58 | 254,260,598.42 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 274,400,000 | 274,400,000 | 274,400,000 | 274,400,000 |
| 资本公积 | 1,175,415,514.58 | 1,175,415,514.58 | 1,175,415,514.58 | 1,175,415,514.58 |
| 减:库存股 | 10,000,118.23 | 10,000,118.23 | 9,998,136.25 | 7,997,384.37 |
| 盈余公积 | 20,100,414.53 | 20,100,414.53 | 20,100,414.53 | 20,100,414.53 |
| 未分配利润 | -531,351,997.27 | -523,323,689.01 | -223,635,962.53 | -156,247,362.39 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 928,563,813.61 | 936,592,121.87 | 1,236,281,830.33 | 1,305,671,182.35 |
| 少数股东权益 | -58,359,447.16 | -58,286,246.19 | -26,625,549.2 | -16,976,592.55 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 870,204,366.45 | 878,305,875.68 | 1,209,656,281.13 | 1,288,694,589.8 |
| 负债和股东权益合计 | 1,212,138,325.93 | 1,222,438,490.23 | 1,368,560,964.71 | 1,542,955,188.22 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-31 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |